HLN.L vs PBH
HLN.L: A leading global consumer healthcare business managing a portfolio of world-class brands in pain relief, oral health, and wellness. PBH: Prestige Consumer Healthcare is a branded OTC healthcare company that manages a diverse portfolio of essential household and personal care products.
Side-by-side fundamentals
| Metric | HLN.L | PBH | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | £3.73 | $47.92 | |
| Market cap | $44.3B | $2.3B | |
| P/E | 20.21 | 13.42 | PBH lower |
| Net margin | +15.2% | +17.5% | PBH higher |
| Gross margin | +64.2% | +54.7% | HLN.L higher |
| Operating margin FY2026, SEC XBRL | n/a | +28.4% | |
| ROE | +10.2% | +10.1% | HLN.L higher |
| ROA FY2026, SEC XBRL | n/a | +5.4% | |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | n/a | 1.05 | |
| Revenue growth (YoY) FY2026, SEC XBRL | n/a | -4.3% | |
| Revenue CAGR (3y) SEC XBRL | n/a | -1.2% | |
| Dividend streak (yrs) SEC XBRL | n/a | 0 | |
| Beta as of 2026-09-02 | n/a | 0.39 | |
| 1-year return as of 2026-10-21 close | +6.8% | -23.3% | HLN.L higher |
Fundamentals: SEC XBRL company filings and annual report filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.